Drug shortage
Atropine Sulfate Injection · Accord Healthcare Inc.
FDA drug shortage · Current · updated Apr 2, 2025
Key facts
| Generic name | Atropine Sulfate Injection |
|---|---|
| Proprietary name | Atropine Sulfate |
| Company | Accord Healthcare Inc. |
| Presentation | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) |
| Dosage form | Injection |
| Strength | .4 mg/1 mL |
| Status | Current |
| Reason for shortage | Requirements related to complying with good manufacturing practices |
| Therapeutic category | Anesthesia Neurology Pediatric |
| Package NDCs | 16729-525-08 |
| First posted | Jan 1, 2012 |
| Last updated | Apr 2, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: